Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Other Accumulated Expenses (2021 - 2024)

Lucid Diagnostics (LUCD) has disclosed Other Accumulated Expenses for 4 consecutive years, with $869000.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Other Accumulated Expenses fell 56.94% year-over-year to $869000.0, compared with a TTM value of $869000.0 through Dec 2024, down 56.94%, and an annual FY2024 reading of $869000.0, down 56.94% over the prior year.
  • Other Accumulated Expenses was $869000.0 for Q4 2024 at Lucid Diagnostics, up from $53000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $10.3 million in Q3 2023 and bottomed at $53000.0 in Q3 2024.
  • Average Other Accumulated Expenses over 4 years is $2.6 million, with a median of $1.4 million recorded in 2024.
  • The sharpest move saw Other Accumulated Expenses soared 834.09% in 2022, then tumbled 99.48% in 2024.
  • Year by year, Other Accumulated Expenses stood at $531000.0 in 2021, then skyrocketed by 834.09% to $5.0 million in 2022, then tumbled by 59.31% to $2.0 million in 2023, then plummeted by 56.94% to $869000.0 in 2024.
  • Business Quant data shows Other Accumulated Expenses for LUCD at $869000.0 in Q4 2024, $53000.0 in Q3 2024, and $266000.0 in Q2 2024.